Somewhat Favorable News Coverage Somewhat Unlikely to Affect Metlife (MET) Share Price

Press coverage about Metlife (NYSE:MET) has trended somewhat positive on Tuesday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Metlife earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.3867351954399 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

A number of brokerages have weighed in on MET. Deutsche Bank initiated coverage on shares of Metlife in a research report on Tuesday. They issued a “hold” rating for the company. ValuEngine cut shares of Metlife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. Wells Fargo & Co reaffirmed an “outperform” rating and set a $60.00 price objective (up previously from $55.00) on shares of Metlife in a research note on Tuesday, October 3rd. They noted that the move was a valuation call. B. Riley reaffirmed a “neutral” rating on shares of Metlife in a research note on Monday, November 6th. Finally, Zacks Investment Research raised shares of Metlife from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research note on Thursday, November 9th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. Metlife currently has a consensus rating of “Hold” and an average price target of $58.52.

Shares of Metlife (NYSE MET) opened at $50.56 on Tuesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 0.16 and a quick ratio of 0.16. The company has a market cap of $53,204.24, a P/E ratio of -101.12, a price-to-earnings-growth ratio of 1.27 and a beta of 1.49. Metlife has a 52-week low of $44.26 and a 52-week high of $55.91.

Metlife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.19. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The company had revenue of $16.10 billion for the quarter, compared to the consensus estimate of $15.47 billion. During the same period last year, the firm posted $1.28 EPS. Metlife’s revenue for the quarter was up 1.7% on a year-over-year basis. equities research analysts anticipate that Metlife will post 4.42 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, December 13th. Stockholders of record on Monday, November 6th were paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 3.16%. The ex-dividend date of this dividend was Friday, November 3rd. Metlife’s dividend payout ratio (DPR) is presently -320.00%.

In other Metlife news, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction that occurred on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the transaction, the insider now directly owns 49,660 shares of the company’s stock, valued at $2,711,436. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction on Monday, November 6th. The stock was sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the transaction, the insider now directly owns 25,181 shares in the company, valued at $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is owned by company insiders.

WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Metlife (MET) Share Price” was originally posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://www.truebluetribune.com/2018/01/02/metlife-met-receives-daily-news-sentiment-rating-of-0-13.html.

Metlife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply